// App-Quantinova.ai

2159 : Gastroesophageal Reflux Disease in an Australian Scleroderma Cohort – Associations and Effect of Treatment

Researchers

Presenter

  • Alannah Quinlivan

Principal Investigators

  • Dennis Neuen

  • Dylan Hansen

  • Wendy Stevens

  • Laura Ross

  • Nava Ferdowsi

  • Susanna Proudman

  • Jenny Walker

  • Jo Sahhar

  • Gene-Siew Ngian

  • Diane Apostolopoulos

  • Lauren Host

  • Gabor Major

  • Kathleen Morrisroe

  • Mandana Nikpour

Medical Centers

  • Vincent's Hospital and The University of Melbourne, Melbourne, Australia

  • Liverpool Hospital, Sydney, Australia

  • St Vincent's Hospital, Melbourne, Australia

  • The University of Melbourne at St. Vincent's Hospital, Brunswick, Australia

  • University of Adelaide, Adelaide, Australia

  • Flinders Medical Centre, Flinders University, Adelaide, Australia

  • Monash Health, Melbourne, Australia

  • Melbourne Health, Northcote, Australia

  • Deakin University, Melbourne, Australia

  • Fiona Stanley Hospital, London, United Kingdom

  • Hunter New England Health Service, Rankin Park - Newcastle, New South Wales, Australia

  • Medicine, The University of Melbourne at St. Vincents Hospital, Melbourne, Australia

Locations

  • United States

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Gastroenterology (GU)

Disease

  • Gastroesophageal reflux disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • histamine

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A